Vascular & Endovascular

This channel includes news on non-coronary vascular disease and therapies. These include peripheral artery disease (PAD), abdominal and thoracic aortic aneurysm (AAA and TAA), aortic dissection, pulmonary embolism (PE), critical limb ischemia (CLI), carotid artery and stroke interventions, venous interventions, deep vein thrombosis (DVT), and interventional radiology therapies. The focus on most of these therapies is minimally invasive, catheter-based procedures performed in a cath lab.

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications
Johnson & Johnson MedTech's Varipulse PFA system has been linked to multiple reports of "neurovascular events" in patients. The company hopes to share more information in the days ahead.
Stryker acquires Inari Medical for $4.9B
Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.
‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors
Approximately 800,000 strokes occur each year in the United States alone. A majority of people survive, due in part to key advances in patient care over the years, but they often go forward without receiving the long-term help they need to recover and thrive.
Advancing AI for vascular surgery will require a commitment to data integrity
For artificial intelligence to truly transform care, the healthcare industry must address certain challenges. Jens Eldrup-Jorgensen, MD, a veteran vascular surgeon and member of the Society for Vascular Surgery, explains in a guest editorial.
Industry concerns over paclitaxel-coated devices may have put PAD patients at risk
Back in 2019, the FDA issued a warning about the use of paclitaxel-coated devices when treating peripheral artery disease. The agency took back that warning in 2023, but it appears to have made a significant impact on patient care.

FDA announces recall of blood lead tests due to 'significant concerns'

Any patients assessed by these tests may need to have their results reviewed by a specialist.

July 2, 2021

Prasugrel outperforms ticagrelor among PCI patients

The study's authors tracked data from more than 3,000 patients who underwent PCI for acute coronary syndrome.

June 30, 2021

Abbott gains key DAPT approvals for Xience stents in US, Europe

DAPT for patients at a high risk of bleeding can now be as short as 28 days with the Xience line of stents, the company announced.

June 30, 2021

FDA approves first oral blood thinner for pediatric patients

The approval includes patients as young as three months old.

June 23, 2021

Time for a change? AFib patients may want to stop drinking alcohol

Alcohol consumption is associated with a heightened risk of stroke among patients with newly diagnosed atrial fibrillation.

June 18, 2021

How later COVID-19 surges impacted heart attack and stroke numbers

This new analysis helps paint a better picture of how COVID-19 has affected patient care in the United States.

June 3, 2021

FDA announces recall of more than 30,000 Boston Scientific stent systems after numerous injuries

In total, the recall affects 31,798 venous stent systems distributed to customers from September 2018 to April 2021.

May 21, 2021

High blood pressure linked to greater risk of heart failure, AFib, heart attack, stroke

The authors evaluated data from more than 2.1 million patients, sharing their findings in Circulation.

May 13, 2021

Vascular & Endovascular

Johnson & Johnson pauses use of FDA-approved PFA system to investigate patient complications

Stryker acquires Inari Medical for $4.9B

‘Fundamental for all patients’: Exploring the benefits of palliative care for stroke survivors

Advancing AI for vascular surgery will require a commitment to data integrity

Industry concerns over paclitaxel-coated devices may have put PAD patients at risk